Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02719795Phase 1Unknown
Phase 1, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: The incidence of chronic postoperative pain for 3 months after modified radical mastectomy surgery. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02719795.